Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2010

View Archived Issues

Recombinant polypeptide can extend half-life of proteins and peptides

Penwest initiates phase IIa trial of A-0001 in A3243G mitochondrial DNA point mutation

Detection of label-free biomarkers in whole blood samples reported

HSV-2 suppression with acyclovir does not reduce risk for HIV-1 transmission

Combined targeting of beta/gamma-secretase shows promise as new AD therapy

New therapeutic target found in NS4B protein of hepatitis C virus

Ablynx selected anti-CXCR4 Nanobody ALX-0651 for preclinical development

FDA approves SPA for phase III trial of HyperAcute immunotherapy in pancreatic cancer

Excelimmune receives Series B funding for development of Staphguard

Anacor regains worldwide rights to AN-2690 from Merck

Circassia reports phase II results with ragweed allergy T-cell vaccine

Synta reports STA-9090 results showing potent in vitro and in vivo activity in AML

FDA extends Horizant PDUFA date

Cerus reports outcome of phase I trial of Intercept red blood cells

PolyMedix reports milestones scheduled for 2010

Tyrogenex presents protein kinase inhibitors for cancer therapy

Theracos identifies novel sodium/glucose cotransporter inhibitors

New MR antagonists discovered at Bayer Schering Pharma

S1P1 receptor agonists discovered by GlaxoSmithKline

Janus kinase inhibitors identified by Merck & Co.

Genta initiates phase II tesetaxel trial in patients with advanced melanoma

YM BioSciences presents CYT-387 and CYT-997 data

Euthymics Bioscience signs letter of intent for acquisition of DOV

KineMed broadens collaboration with Bristol-Myers Squibb

Proteonomix forms wholly owned subsidiary PRTMI for stem cell research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...